Ashler et Manson SA
Ashler et Manson SA Fundamental Analysis
Ashler et Manson SA (MLAEM.PA) shows moderate financial fundamentals with a PE ratio of 0.00, profit margin of 15.64%, and ROE of 4.73%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 56.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze MLAEM.PA's fundamental strength across five key dimensions:
Efficiency Score
WeakMLAEM.PA struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMLAEM.PA trades at attractive valuation levels.
Growth Score
ModerateMLAEM.PA shows steady but slowing expansion.
Financial Health Score
ExcellentMLAEM.PA maintains a strong and stable balance sheet.
Profitability Score
WeakMLAEM.PA struggles to sustain strong margins.
Key Financial Metrics
Is MLAEM.PA Expensive or Cheap?
P/E Ratio
MLAEM.PA trades at 0.00 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, MLAEM.PA's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Ashler et Manson SA at 0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 1187.59 times EBITDA. This signals the market has high growth expectations.
How Well Does MLAEM.PA Make Money?
Net Profit Margin
For every $100 in sales, Ashler et Manson SA keeps $15.64 as profit after all expenses.
Operating Margin
Core operations generate 19.58 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $4.73 in profit for every $100 of shareholder equity.
ROA
Ashler et Manson SA generates $3.52 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
MLAEM.PA converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.00
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
240.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.14
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.94
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How MLAEM.PA Stacks Against Its Sector Peers
| Metric | MLAEM.PA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.00 | 18.89 | Better (Cheaper) |
| ROE | 4.73% | 814.00% | Weak |
| Net Margin | 15.64% | 889.00% | Weak |
| Debt/Equity | 0.14 | 0.98 | Strong (Low Leverage) |
| Current Ratio | 1.94 | 618.44 | Neutral |
| ROA | 3.52% | -20907.00% (disorted) | Weak |
MLAEM.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ashler et Manson SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical